Assignee
AXON NEUROSCIENCE SE
SK·7 granted patents·3 pending applications·14 citations·filing 2015–2021
Top patents by PatentIndex Score
10 records- 0187US10160799B2Humanized tau antibodies in a alzheimer's diseaseAXON NEUROSCIENCE SE·Filed 2015·Granted Dec 25, 2018·4 cites·58 claims
- 0282US11098106B2Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's diseaseAXON NEUROSCIENCE SE·Filed 2017·Granted Aug 24, 2021·3 cites·43 claims
- 0381US9828421B2Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's diseaseAXON NEUROSCIENCE SE·Filed 2016·Granted Nov 28, 2017·4 cites·24 claims
- 0480US9845352B2Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's diseaseAXON NEUROSCIENCE SE·Filed 2017·Granted Dec 19, 2017·3 cites·30 claims
- 0572US12404322B2Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's diseaseAXON NEUROSCIENCE SE·Filed 2021·Granted Sep 2, 2025·0 cites·23 claims
- 0665US10745469B2Humanized tau antibodies in alzheimer's diseaseAXON NEUROSCIENCE SE·Filed 2018·Granted Aug 18, 2020·0 cites·23 claims
- 0764US11319363B2Humanized tau antibodies in Alzheimer's diseaseAXON NEUROSCIENCE SE·Filed 2020·Granted May 3, 2022·0 cites·27 claims
- 0854US2016106077A1Transgenic Animal Expressing Alzheimer's Tau ProteinAXON NEUROSCIENCE SE·Filed 2015·Application pending·0 cites
- 0950US2022402979A1Biomarkers and treatments of alzheimer's disease and mild cognitive impairmentAXON NEUROSCIENCE SE·Filed 2020·Application pending·0 cites
- 1043US2021139568A1Antibody-based methods of detecting and treating alzheimer's diseaseAXON NEUROSCIENCE SE·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AXON NEUROSCIENCE SE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →